David Michael Johnson, Director at Aura Biosciences, Inc. (AURA), bought 2,000 shares at $10.00 ($21K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market purchase of $21k AURA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 96 | $960 | 4.6% |
| 2 | $10.00 | 300 | $3K | 14.4% |
| 3 | $10.50 | 700 | $7K | 35.3% |
| 4 | $10.51 | 904 | $10K | 45.7% |
| Total | $10.41 avg | 2,000 | $21K | 100% |
| Filing → |
| AURA | BUY | 2023-11-09 | $1.1M | — | Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2022-12-30 | $20K | — | Filing → |